Skip to main content

Table 3 Baseline data, test results, electrocardiography findings, echocardiographic data, and computed tomography measurements in patient groups

From: Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty): a retrospective cohort study

Variable

Group without conduction disorders (n = 35)

Group with conduction disorders (n = 33)

P value

Sex (male)

21 (60.0%)

14 (42.4%)

0.225

Age (years)

76.63 ± 7.42

72.31 ± 8.4.2

0.135

BMI (kg/m2)

21.25 ± 2.70

20.87 ± 2.72

0.697

STS score

7.69 ± 1.25

8.13 ± 1.75

0.422

Past medical history

   

Hypertension

24 (68.6%)

21 (63.6%)

0.799

Coronary heart disease

7 (20.0%)

10 (30.3%)

0.406

Diabetes

3 (8.6%)

7 (21.2%)

0.259

Laboratory data

   

Leukocyte count (*109/L)

5.61 ± 1.62

4.83 ± 1.11

0.119

Red blood cells count(*1012/L)

3.94 ± 0.58

3.87 ± 0.46

0.694

Hemoglobin level (g/L)

117.13 ± 18.3

117.56 ± 13.75

0.940

Platelet count (*109/L)

157.50 ± 60.54

157.75 ± 52.25

0.990

Total cholesterol level (mmol/L)

3.73 ± 0.82

3.77 ± 1.29

0.913

Low-density cholesterol level (mmol/L)

2.00 ± 0.72

2.10 ± 0.91

0.736

Creatinine level (µmol/L)

89.08 ± 30.70

85.78 ± 41.68

0.800

Fasting glucose level (mmol/L)

4.66 ± 0.55

4.96 ± 0.78

0.224

High-sensitivity troponin level (ng/mL)

0.009 (0.008,0.020)

0.010 (0.005,0.028)

0.742

CKMB level (U/L)

16.05 ± 4.71

13.86 ± 3.59

0.095

BNP level (pg/mL)

294 (100,766)

260 (156,425)

0.368

Electrocardiography findings

   

Preoperative QRS width (ms)

104.06 ± 21.82

107.63 ± 23.2

0.658

Preoperative cRBBB or first-degree AV block

4 (11.4%)

8 (24.2%)

0.166

Echocardiography

   

LA (mm)

44.56 ± 5.27

41.56 ± 7.30

0.193

LV (mm)

55.05 ± 7.29

59.57 ± 9.51

0.086

IVS (mm)

9.97 ± 1.32

9.81 ± 2.32

0.817

LVEF (%)

52.25 ± 8.70

53.63 ± 10.46

0.689

Mitral curtain length

4.88 ± 1.20

4.94 ± 1.12

1

LVOT type (non-tubular)

14 (29.6%)

16(80%)

0.008

CT data

   

Mean diameter of AA (mm)

24.29 ± 2.19

24.72 ± 2.84

0.639

Mean diameter of LVOT (mm)

24.80 ± 3.21

2465 ± 3.72

0.904

Mean diameter of STJ (mm)

35.13 ± 3.39

34.68 ± 3.84

0.728

Angle of the aortic root (°)

55.23 ± 5.99

61.48 ± 8.72

0.009

Mean diameter of AAO (mm)

42.96 ± 2.67

41.55 ± 5.22

0.345

AA calcification

4 (11.4%)

5 (15.2%)

0.730

LVOT calcification

2 (5.7%)

2 (6.1%)

1

Valve device and TAVR intervention procedure dates

   

Valve device type (mm)

28.8 ± 1.897

28.6 ± 1.92

0.776

Valve implantation depth (mm)

0.00 (0.00, 4.00)

5.92 (3.31 6.13)

0.001

Others

   

Largest diameter of the upper corolla of the valve device/diameter of AAO

1.00 ± 0.06

1.05 ± 0.12

0.170

Diameter of the inferior edge of valve device/diameter of aortic annular

1.25 ± 0.07

1.23 ± 0.08

0.618

Diameter of the inferior edge of valve device/Mean diameter of LVOT

1.24 ± 0.11

1.25 ± 0.13

0.705

Mean diameter of LVOT/Mean diameter of aortic annular

1.02 ± 0.07

1.00 ± 0.06

0.308

  1. BMI: body mass index; BNP: brain natriuretic peptide; cRBBB: complete right bundle branch block; CKMB: creatine kinase-myoglobin binding; LVOT: left ventricular outflow tract; CT: computed tomography; STJ: sinotubular junction; LA: left atrium; LV: left ventricle: IVS: interventricular septal; LVEF: left ventricular ejection fraction